Nick Kenny, an executive at since 2006, will lead oncology efforts at the firm, the company said Tuesday.
Kenny’s new title is senior vice president of oncology. He has held three other positions related to oncology in his tenure at the Raleigh-based international congract research organization.
“Nick was the obvious choice to step into this senior management role in oncology,” said John Potthoff,INC’s chief operating officer. “Not only does he have impeccable therapeutic expertise, but he has been instrumental in fine tuning the methodologies that we use today in our trusted process for delivering high quality clinical results that meet or exceed customer expectations.”
Kenny has been involved in oncology research over the past 10 years. He also has performed research in cell biology and endocrinology.
